NEUROLOGY 1992;42:1798
© 1992 American Academy of Neurology
Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSG and two pentapepfide seauence identities between EBNA A and myelin basic protein
Patrick F. Bray, MD,
J. Luka, PhD,
Paul F. Bray, MD,
K. W. Culp, BS and
J. P. Schlight, BS
Departments of Neurology and Pediatrics, University of Utah, Salt Lake City, UT (Dr. Patrick F. Bray, K.W. Culp, and J.P. Schlight)
Departments of Pathology and Microbiology, University of Nebraska, Omaha, NE (Dr. Luka)
Department of Medicine, Division of Hematology, Johns Hopkins School of Medicine, Baltimore, MD (Dr. Paul F. Bray).
The Epstein-Barr virus (EBV) causes infectious mononucleosis and is linked to several disparate malignancies. Prior studies on patients with multiple sclerosis (MS) showed that 100% are EBV-seropositive and that their blood contains higher antibody titers than those of controls to both transformation and lytic cycle antigens. We performed three different assays for antibodies in CSF to three major EBV antigens from patients with MS and controls. Among 93 patients with MS, 79 (85%) had CSF that reacted with a 70 kD protein, shown to be the nuclear antigen, EBNA-1, whereas only 11 (13%) of 81 EBV-seropositive controls reacted, p < 0.001. The CSF of all 14 MS patients, unreactive on immunoblots, contained oligoclonal bands on agarose electrophoresis. Together, the two techniques exhibit 100% sensitivity in the confirmatory diagnosis of MS. We also performed amino acid searches of the Protein Identification Resource sequence database for protein homologies to EBNA. Two pentapeptide identities were found between EBNA-1 and myelin basic protein: QKRPS and PRHRD. None of more than 32,000 other proteins in the database contained both pentapeptides. In healthy EBV-seropositive persons, the EBV-specific, MHC-restricted T lymphocytes keep the EBV-containing B lymphocytes locked in the transformed state. However, in the host genetically susceptible to MS, the same population of lymphocytes might recognize and interact with either of the two identified pentapeptides, inadvertently damaging MBP.
Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein
Supported in part by the Clipped Wings (flying personnel, United Airlines), Richard Uriarte, and the Utah Association of Life Underwriters. Dr. Paul F. Bray is the recipient of an NIH Physician Scientist Award HL 01815, an NIH First Award HL 43020, and an American Heart Association Established Investigatorship 90151.
Address correspondence and reprint requests to Dr. Patrick F. Bray, University of Utah College of Medicine, 50 N. Medical Drive, Salt Lake City, UT 84132.
Received December 18, 1991. Accepted for publication in final form February 13, 1992.
This article has been cited by other articles:
|
|
|
|
 
S. N. Willis, C. Stadelmann, S. J. Rodig, T. Caron, S. Gattenloehner, S. S. Mallozzi, J. E. Roughan, S. E. Almendinger, M. M. Blewett, W. Bruck, et al.
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain
Brain,
December 1, 2009;
132(12):
3318 - 3328.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Yamout, J. Usta, S. Itani, and S. Yaghi
Celiac disease, Behcet, and idiopathic thrombocytopenic purpura in siblings of a patient with multiple sclerosis
Multiple Sclerosis,
November 1, 2009;
15(11):
1368 - 1371.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M H J Vogt, C E Teunissen, E Iacobaeus, D A M Heijnen, E C W Breij, T Olsson, L Brundin, J Killestein, and C. D Dijkstra
Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
October 1, 2009;
80(10):
1110 - 1115.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Farrell, D. Antony, G. R. Wall, D. A. Clark, L. Fisniku, J. Swanton, Z. Khaleeli, K. Schmierer, D. H. Miller, and G. Giovannoni
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI
Neurology,
July 7, 2009;
73(1):
32 - 38.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Serafini, B. Rosicarelli, D. Franciotta, R. Magliozzi, R. Reynolds, P. Cinque, L. Andreoni, P. Trivedi, M. Salvetti, A. Faggioni, et al.
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
J. Exp. Med.,
November 26, 2007;
204(12):
2899 - 2912.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Lunemann, T. Kamradt, R. Martin, and C. Munz
Epstein-Barr Virus: Environmental Trigger of Multiple Sclerosis?
J. Virol.,
July 1, 2007;
81(13):
6777 - 6784.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Lunemann, N. Edwards, P. A. Muraro, S. Hayashi, J. I. Cohen, C. Munz, and R. Martin
Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis
Brain,
June 1, 2006;
129(6):
1493 - 1506.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Sundstrom, P. Juto, G. Wadell, G. Hallmans, A. Svenningsson, L. Nystrom, J. Dillner, and L. Forsgren
An altered immune response to Epstein-Barr virus in multiple sclerosis: A prospective study
Neurology,
June 22, 2004;
62(12):
2277 - 2282.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Alotaibi, J. Kennedy, R. Tellier, D. Stephens, and B. Banwell
Epstein-Barr Virus in Pediatric Multiple Sclerosis
JAMA,
April 21, 2004;
291(15):
1875 - 1879.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.-P. Wandinger, W. Jabs, A. Siekhaus, S. Bubel, P. Trillenberg, H.-J. Wagner, K. Wessel, H. Kirchner, and H. Hennig
Association between clinical disease activity and Epstein-Barr virus reactivation in MS
Neurology,
July 25, 2000;
55(2):
178 - 184.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. A Hay and R. B Tenser
Leukotropic herpesviruses in multiple sclerosis
Multiple Sclerosis,
April 1, 2000;
6(2):
66 - 68.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. H Rand, H. Houck, N. D Denslow, and K. M Heilman
Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
July 1, 1998;
65(1):
48 - 55.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K.-M. Myhr, T. Riise, E. Barrett-Connor, H. Myrmel, C. Vedeler, M. Gronning, M. B. Kalvenes, and H. Nyland
Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway
J. Neurol. Neurosurg. Psychiatry,
April 1, 1998;
64(4):
539 - 542.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
